Hemoglobin Oxygen Therapeutics LLC (HOTI)
Hemoglobin Oxygen Therapeutics LLC will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 |
|---|---|---|
| Selling, General & Admin | 2.67 | 2.67 |
| Research & Development | 0.77 | 0.57 |
| Operating Expenses | 3.44 | 3.25 |
| Operating Income | -3.44 | -3.21 |
| Interest Expense / Income | -0.68 | -0.38 |
| Other Expense / Income | 3.37 | 0.76 |
| Pretax Income | -6.13 | -3.59 |
| Net Income | -6.13 | -3.59 |
| EBITDA | -6.21 | -3.42 |
| Depreciation & Amortization | 0.6 | 0.55 |
| EBIT | -6.81 | -3.97 |
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).